Publications
5808 Results
- Journal / Conference
- Clinical Cancer Research 15(18):5663-5770
- Year
- 2009
- Research Committee(s)
- Gastrointestinal, Genitourinary, and Multiple sites
- Study Number(s)
- SWOG-8794, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives workshop 2008 [PMID19723641; PMC2978526]
- Journal / Conference
- Journal of Clinical Oncology 27(21)3540-3546
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0003
Japan-USA common arm analysis of paclitaxel-carboplatin in advanced non-small cell lung cancer: a model for assessing population-related pharmacogenomics [PMC2717760; PMID19470925]
- Journal / Conference
- Journal of Thoracic Oncology 4(9)suppl 1, abst. PD8.2.6,S522, 2009 (IASLC 13th World Conf on Lung Cancer, poster)
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0220
Docetaxel is not feasible as consolidation therapy after cisplatin/etoposide/concurrent radiotherapy followed by surgical resection for pancoast tumors: preliminary results of SWOG 0220
- Journal / Conference
- Journal of Thoracic Oncology 4(9);suppl 1, abst. #B2.7, S326;
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0003, SWOG-9308, S9806
Chemotherapy outcomes by histologic subtype of non-small cell lung cancer (NSCLC): analysis of the SWOG database for antimicrotubule-platinum therapy
- Journal / Conference
- ASCO 2009 Genitourinary Cancers Symposium, abstract #1
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
The selenium and vitamin E cancer prevention trial (SELECT): Southwest Oncology Group Study
- Journal / Conference
- Western Association of Gynecologic Oncologists (WAGO) Annual Meeting, poster presentation
- Year
- 2009
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0009
Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with enoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group study
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst.#8522
- Year
- 2009
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0120
Role of T-cell immunity to embryonal stem (ES) cell antigen SOX2 in the progression of myeloma
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst. #10520
- Year
- 2009
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0345
Combined analysis of two phase II trials of imatinib in advanced dermatofibrosarcoma protuberans (DFSP)
- Journal / Conference
- Journal of Clinical Oncology 27:15s, abst.#8015
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0536